BIO Elects New Board Directors and
Re-Elects Section Governing Board Chairs
San Diego, Calif. (June 15, 2022) – The Biotechnology Innovation Organization (BIO) is pleased to announce the election of its new Executive Committee directors for the 2022-2023 term.
BIO’s Board elections took place Monday, June 13 during the 2022 BIO International Convention hosted by BIO in San Diego, June 13-16, 2022.
“On behalf of our entire BIO organization, I want to congratulate our incoming Board directors and section leaders,” said Dr. Michelle McMurry-Heath, President & CEO of BIO. “This is a critical time for our industry. Our BIO Board – especially one as diverse and multi-faceted as this one – will help drive policies that keeps pace with innovation’s promise to cure disease, nourish society, and protect our planet.”
BIO’s Executive Committee directors for the 2022-2023 term are:
§ Paul Hastings, Nkarta Therapeutics – Board Chair/Health Section Chair
§ Elizabeth Lewis, Takeda Pharmaceuticals – Board Associate Vice Chair & Secretary
§ Bradford Zakes, Ceravast Medical – BIO Board Treasurer
§ Ted Love, Global Blood Therapeutics – Health Section Vice Chair
§ Sylvia Wulf, AquaBounty Technologies – Agriculture & Environment Section Chair
§ John Crowley, Amicus Therapeutics – Emerging Companies Section Chair
§ Jeremy Levin, Ovid Therapeutics – Immediate Past Chair
§ Erika Smith, ReNetX BIO – Emerging Companies Section Vice Chair
§ Anna Rath, Vestaron
§ Doug Doerfler, MaxCyte
§ Stuart Arbuckle, Vertex Pharmaceuticals
§ Christi Shaw, Kite, A Gilead Company
§ Bill Sibold, Genzyme, A Sanofi Company
§ Fritz Bittenbender, Genentech Roche
§ Chris Boerner, Bristol Myers Squibb
§ Eric Dube, Travere Therapeutics
§ Sue Washer, Applied Genetic Technologies Corporation (AGTC)
§ Aamir Malik, Pfizer
§ Jannie Oosthuizen, Merck
§ Victor Bulto, Novartis Pharmaceuticals
§ Bill Newell, Sutro BioPharma
Additional directors who were confirmed as the Executive Advisory Board (EAB) to the Executive Committee:
§ Ron Cohen, Acorda Therapeutics
§ Rachel King, former BIO Board Chair
§ John Maraganore, former BIO Board Chair
§ Richard Pops, Alkermes
Newly Elected to the BIO Health Section Governing Board (2022-2025 Term):
§ Jannie Oosthuizen, Merck
Newly Elected to the BIO Emerging Companies Section Governing Board (2022-2023 Term):
§ Pablo Cagnoni, Rubius Therapeutics
§ Kaye Foster, The Boston Consulting Group
§ Mike Huckman, Real Chemistry
§ Elizabeth Jeffords, Iolyx Therapeutics
§ Sheila Mikhail, Asklepios BioPharmaceutical
Newly Elected to the BIO Agriculture and Environment Section Governing Board (2022-2024 Term):
§ Angela Ailloni, Ginkgo Bioworks
§ Rocco Morelli, Recombinetics
沒有留言:
發佈留言